amlodipine and olmesartan medoxomil (67877-502)

Drug Facts

Product Profile

Brand Name amlodipine and olmesartan medoxomil

Generic Name amlodipine and olmesartan medoxomil

Labeler ascend laboratories, llc

Dosage Form TABLET

Routes

ORAL

Active Ingredients

amlodipine besylate 10 mg/1, olmesartan medoxomil 40 mg/1

Manufacturer

Ascend Laboratories, LLC

Identifiers & Regulatory

Product NDC 67877-502

Product ID 67877-502_32238052-6c4c-4b29-a59e-524c819c69f1

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA209042

Listing Expiration 2026-12-31

Marketing Start 2017-08-14

Pharmacologic Class

Classes

angiotensin 2 receptor antagonists [moa] angiotensin 2 receptor blocker [epc] calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] dihydropyridine calcium channel blocker [epc] dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67877502

Hyphenated Format 67877-502

Supplemental Identifiers

RxCUI

730861 730866 730869 730872

UNII

864V2Q084H 6M97XTV3HD

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name amlodipine and olmesartan medoxomil (source: ndc)

Generic Name amlodipine and olmesartan medoxomil (source: ndc)

Application Number ANDA209042 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

10 mg/1
40 mg/1

source: ndc

Packaging

30 TABLET in 1 BOTTLE (67877-502-30)
90 TABLET in 1 BOTTLE (67877-502-90)

source: ndc

Packages (2)

67877-502-30 30 TABLET in 1 BOTTLE (67877-502-30) 67877-502-90 90 TABLET in 1 BOTTLE (67877-502-90)

Ingredients (2)

amlodipine besylate (10 mg/1) olmesartan medoxomil (40 mg/1)

Linked Drug Pages (1)

Amlodipine and olmesartan Medoxomil ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "32238052-6c4c-4b29-a59e-524c819c69f1", "openfda": {"unii": ["864V2Q084H", "6M97XTV3HD"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_set_id": ["c1204fbe-d086-43cf-bbaa-efec9cd0487c"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (67877-502-30)", "package_ndc": "67877-502-30", "marketing_start_date": "20170814"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (67877-502-90)", "package_ndc": "67877-502-90", "marketing_start_date": "20170814"}], "brand_name": "Amlodipine and olmesartan Medoxomil", "product_id": "67877-502_32238052-6c4c-4b29-a59e-524c819c69f1", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "67877-502", "generic_name": "Amlodipine and olmesartan Medoxomil", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and olmesartan Medoxomil", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA209042", "marketing_category": "ANDA", "marketing_start_date": "20170814", "listing_expiration_date": "20261231"}